Paul Gray Parker - 30 Dec 2022 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
30 Dec 2022
Net transactions value
+$7,718
Form type
4
Filing time
04 Jan 2023, 16:08:39 UTC
Previous filing
04 Oct 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock Award $7,718 +55 +18% $140.33 366 30 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +8 +0.82% $0.000000 948 10 Nov 2022 Common Stock 8 Direct F2, F3, F4
transaction CLX Deferred Stock Units Award $0 +1,073 +113% $0.000000 2,021 30 Dec 2022 Common Stock 1,073 Direct F2, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Receipt of Common Stock in lieu of portion of quarterly director's fee.
F2 1-for-1
F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F5 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.